PatientsVille.com Logo

MYOCARDIAL INFARCTION and Klonopin

PatientsVille

MYOCARDIAL INFARCTION Symptoms and Causes

Each year over a million people in the U.S. have a heart attack. About half of them die. Many people have permanent heart damage or die because they don't get help immediately. It's important to know the symptoms of a heart attack and call 9-1-1 if someone is having them. Those symptoms include

  • Chest discomfort - pressure, squeezing, or pain
  • Shortness of breath
  • Discomfort in the upper body - arms, shoulder, neck, back
  • Nausea, vomiting, dizziness, lightheadedness, sweating

These symptoms can sometimes be different in women.

What exactly is a heart attack? Most heart attacks happen when a clot in the coronary artery blocks the supply of blood and oxygen to the heart. Often this leads to an irregular heartbeat - called an arrhythmia - that causes a severe decrease in the pumping function of the heart. A blockage that is not treated within a few hours causes the affected heart muscle to die.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for MYOCARDIAL INFARCTION

MYOCARDIAL INFARCTION treatment research studies

Klonopin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Klonopin Side Effects

Anxiety (86)
Depression (73)
Convulsion (67)
Dizziness (56)
Insomnia (55)
Nausea (52)
Pain (48)
Headache (41)
Feeling Abnormal (40)
Fatigue (40)
Diarrhoea (38)
Somnolence (33)
Vomiting (32)
Asthenia (29)
Amnesia (29)
Suicide Attempt (28)
Confusional State (28)
Malaise (26)
Overdose (26)
Tremor (26)
Fall (25)
Memory Impairment (23)
Suicidal Ideation (23)
Loss Of Consciousness (23)
Dyspnoea (23)
Balance Disorder (22)
Weight Increased (21)
Abdominal Pain (21)
Panic Attack (20)
Chest Pain (19)
Completed Suicide (19)
Pneumonia (19)
Hallucination (19)
Off Label Use (19)
Injury (18)
Death (18)
Nervousness (18)
Pain In Extremity (18)
Weight Decreased (18)
Gait Disturbance (17)
Hypoaesthesia (17)
Blood Pressure Increased (17)
Condition Aggravated (16)
Arthralgia (16)
Deep Vein Thrombosis (16)
Agitation (16)
Rash (16)
Vision Blurred (16)
Product Substitution Issue (16)
Hyperhidrosis (16)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

MYOCARDIAL INFARCTION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus
Conditions: Status Epilepticus;   Epilepsy
Interventions: Drug: Clonazepam;   Drug: Fosphenytoin;   Drug: Placebo;   Drug: Lorazepam
Outcome Measures: Percentage of patient with a cessation of seizures and absence of recurrence;   Duration between the first cessation and the recurrence of seizures;   Percentage of patients having had a second injection of benzodiazepine;   Percentage of patients having had an injection of the second line treatment;   Percentage of patients having a general anesthesia for refractory status epilepticus;   Percentage of patients having had a side effect;   Percentage of patients having been mechanically ventilated;   Glasgow Coma Scale;   Mortality;   Length of stay in Intensive Care Unit;   Length of stay in hospital
2 Not yet recruiting Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Conditions: Epilepsia Partialis Continua;   Kojewnikov's Epilepsy;   Epilepsy
Interventions: Drug: Clobazam;   Drug: Clonazepam;   Drug: Lorazepam
Outcome Measures: Time (measured in minutes) to onset of seizure freedom;   Reduction of seizure frequency/minute;   Mental status preservation off sedating anticonvulsants as measured by the MoCA© scale;   Ambulatory function as measured by the Hauser Ambulation Index
3 Recruiting Gabapentin Treatment of Benzodiazepine Dependence
Condition: Benzodiazepine Dependence
Interventions: Drug: gabapentin;   Drug: Placebo
Outcome Measure: Abstinence from Benzodiazepine use
4 Unknown  Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
Condition: Status Epilepticus
Intervention: Drug: levetiracetam (add-on)
Outcome Measures: o Uneventful intravenous (iv) administration of study medication;   o Toxicity profile on iv administration, including:;   § Irritation on injection site;   § Hypotension, defined as systolic blood pressure below 90 mm Hg recorded within 24 hours of the dose;   § Cardiac arrest (diagnosed clinically) or bradyarrhythmias including heart block, documented on an electrocardiogram;   § Respiratory depression, defined as the occurrence of apnea or need for intubation;   § Allergic reactions, like skin rash;   § Other side-effects;   Pharmacokinetic parameters of levetiracetam and clonazepam in patients with SE
5 Unknown  The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor
Conditions: Multiple Sclerosis;   Tremor
Intervention: Drug: Botulinum Toxin Type A
Outcome Measures: A decrease in tremor;   The safety profile of Botulinum Toxin in MS patients